Valuation: Alembic Pharmaceuticals Limited

Market Cap 160B 1.67B 1.48B 1.38B 1.26B 2.38B 2.4B 16.73B 6.48B 81.92B 6.26B 6.12B 263B P/E 2027 *
22x
P/E 2028 * 16.6x
Enterprise Value 171B 1.78B 1.58B 1.47B 1.34B 2.53B 2.55B 17.82B 6.91B 87.26B 6.67B 6.52B 280B EV / Sales 2027 *
2.02x
EV / Sales 2028 * 1.8x
Free-Float
29.33%
Yield 2027 *
1.56%
Yield 2028 * 1.88%
1 day+1.54%
1 week-3.11%
Current month+0.28%
1 month+3.53%
3 months-0.94%
6 months+26.20%
Current year-2.17%
1 week 803.5
Extreme 803.5
876.4
1 month 792.6
Extreme 792.6
876.4
Current year 635.8
Extreme 635.8
876.4
1 year 635.8
Extreme 635.8
998
3 years 635.8
Extreme 635.8
1,303.9
5 years 462.3
Extreme 462.3
1,303.9
10 years 414.4
Extreme 414.4
1,303.9
Manager TitleAgeSince
Director of Finance/CFO - 2025-07-06
Compliance Officer - 2026-08-19
Chief Operating Officer - 2025-07-20
Director TitleAgeSince
Chairman 78 2012-06-07
Director/Board Member 51 2006-12-31
Director/Board Member 66 2003-01-17
Date Insider Type Main position Quantity % Market Cap. Importance
3/28/25
Nirayu Pvt Ltd.
BuyCompany 12,665 0.0064%
3/24/25
Nirayu Pvt Ltd.
BuyCompany 7,600 0.0039%
3/21/25 Buy 2,000 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
+1.53%-3.11%-8.67%+6.69% 1.67B
-0.61%-3.43%+36.07%+115.04% 1,019B
-1.02%-5.60%+35.72%+64.63% 617B
+1.11%-0.58%+12.36%+77.95% 464B
+0.34%-3.01%+61.79%+41.24% 356B
-0.95%-4.05%+20.54%+41.71% 333B
-1.46%-2.89%+10.57%+32.81% 267B
-1.35%-5.43%-6.17%+8.98% 244B
-1.04%-2.79%+35.30%+51.84% 218B
-1.87%-4.10%+28.44%+93.66% 179B
Average -0.53%-3.60%+22.60%+53.45% 369.89B
Weighted average by Cap. -0.60%-3.54%+29.06%+70.54%

Financials

2027 *2028 *
Net sales 84.3B 877M 779M 727M 663M 1.25B 1.26B 8.8B 3.41B 43.09B 3.29B 3.22B 138B 93.36B 971M 863M 805M 734M 1.38B 1.4B 9.75B 3.78B 47.73B 3.65B 3.57B 153B
Net income 7.34B 76.35M 67.83M 63.31M 57.71M 109M 110M 766M 297M 3.75B 287M 280M 12.04B 9.71B 101M 89.74M 83.75M 76.34M 144M 145M 1.01B 393M 4.96B 379M 371M 15.93B
Net Debt 10.45B 109M 96.59M 90.15M 82.17M 155M 156M 1.09B 423M 5.34B 408M 399M 17.15B 8.07B 83.97M 74.61M 69.64M 63.47M 120M 121M 843M 327M 4.13B 315M 308M 13.24B
Logo Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing and marketing Indian Formulations, International Generics, and Active Pharmaceutical Ingredients (APIs) across the globe. It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopedic and Gynecology. Its products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It also has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its Indian Formulations.
Employees
17,244
Date Price Change Volume
26-10-05 ₹827.15 +1.46% 147,017
26-10-01 ₹815.25 -1.24% 327,528
26-09-30 ₹825.45 -4.18% 266,145
26-09-29 ₹861.50 +0.84% 457,488
26-09-28 ₹854.35 -1.09% 211,650
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
815.25INR
Average target price
958.80INR
Spread / Average Target
+17.61%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. APLLTD Stock